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 Group II introns insert site-specifically into DNA target sites through a process 
termed retrohoming. They consist of a structured, catalytically active intron RNA and its 
encoded protein. The protein contains several domains, including a reverse transcriptase 
domain and a DNA endonuclease domain used for bottom-strand cleavage. Recently, the 
thermophile Thermosynechococcus elongatus BP-1 was found to contain eight functional 
group II intron-encoded proteins. The proteins are thermostable and active at 
temperatures up to 65°C. The intron-encoded protein, TeI4c displays the greatest reverse 
transcriptase activity of these eight proteins, as well as high fidelity and processivity; 
ideal qualities for a commercial reverse transcriptase. This work explores the possibility 
of using TeI4c for biotechnology applications, and specifically examines the C-terminal 
endonuclease domain of TeI4c and its effect on reverse transcription. Additionally, this 






Table of Contents 
List of Tables……………………………………………………………………….…….vi 
List of Figures…………………………………………………………………………....vii 
Chapter 1: Introduction…………………………………………………………………....1 
1.1 Mechanism of group II intron mobility……………………………………….2 
1.2 Endonuclease-independent retrohoming……………………………………....3 
1.3 Group II introns from Thermosynechoccus elongatus………………………...4 
1.4 Reverse transcriptase activity of TeI4c………………………………………..5 
1.5 DNA target site recognition of TeI4c…………………………………………6 
1.6 Protein structure of HIV-RT and group II intron-encoded proteins………..…7 
1.7 Overview of thesis research…………………………………………………...8 
Chapter 2: Group II intron-encoded reverse transcriptases for biotechnology    
applications…………………………………………………………………..…..17 
 
2.1 Reverse transcriptase activity of TeI4c when fused to NusA………………..18 
2.2 Discussion……………………………………………………………………18 
2.3 Materials and Methods……………………………………………………….19 
Chapter 3: Characterization of the DNA-binding and DNA endonuclease domains of  
 TeI4c RT………………………………………………………………………....24 
 
 3.1 Sequence alignment of TeI4c with LtrA…………………………………......24 
 3.2 Reverse transcriptase activity of C-terminal truncations………………….…25 
 3.3 Discussion……………………………………………………………………27 





Chapter 4: Biochemical characterization of the endonuclease domain of TeI4c and its  
 utilization in retrohoming…………………………………………………...…...35 
 
 4.1 Endonuclease-independent retrohoming of TeI4c…………………………...36 
 4.2 Endonuclease activity of TeI4c………………………………………………39 
 4.3 Discussion……………………………………………………………………40 
 4.4 Materials and Methods…………………………………………………….…42 
Chapter 5: Crystallization of a group II intron-encoded protein…………………………49 
 5.1 TeI4cΔ502 crystallization trials………………………………………….…..49 
 5.2 Discussion……………………………………………………………………50 
















List of Tables 
Table 1.1: Surface entropy mutations for maltose binding protein…….………………..16 























List of Figures 
Figure 1.1: Retrohoming pathway for the L1.LtrB intron………………………………..9 
Figure 1.2: Phylogeny of group II intron-encoded proteins and RNA structure classes..10 
Figure 1.3: Group II intron splicing mechanisms……………………………………..…11 
Figure 1.4: Group II intron RNA secondary structure………………………………..….12 
Figure 1.5: Schematic of a group II intron-encoded protein……………………….….…13 
Figure 1.6: Endonuclease-independent retrohoming mechanisms………………………14 
Figure 1.7: Structure of HIV-RT in a complex with nucleic acid……………………….15 
Figure 2.1: Schematics of MBP-RF-TeI4c and NusA-RF-TeI4c………………………..22 
Figure 2.2: Reverse transcriptase activity of NusA-RF-TeI4c and MBP-RF-TeI4c…….23 
Figure 3.1: Sequence alignment of LtrA and TeI4c……………………………………..30 
Figure 3.2: Schematic of TeI4c C-terminal truncations………………………………….31 
Figure 3.3: Poly(rA)/oligo(dT) reverse transcriptase activity of TeI4c truncations…..…32 
Figure 3.4: Poly(rA)/oligo(dT) reverse transcriptase activity of TeI4c Δ502 from 25-
77°C…………………………………………………………………………………...…33 
 
Figure 3.5: Primer extension reverse transcriptase activity of full-length and truncated 
TeI4c protein……………………………………………………………………...…...…34 
 
Figure 4.1: Plasmid-based intron mobility assay……………………………………..….45 
Figure 4.2: Mobility assays on full-length and Δ502 TeI4c with TeI3c and TeI4c target 
sites………………………………………………………………………………………46 
 
Figure 4.3: TeI4c IEP with TeI4c intron endonuclease assay………………………...…47 
 




Chapter 1: Introduction 
 Group II introns are retrotransposons that insert site-specifically into DNA target 
sites through a process termed retrohoming (Lambowitz and Zimmerly, 2004). They 
consist of a highly structured catalytic RNA (“ribozyme”) and an associated, 
multifunctional intron-encoded protein (IEP) (Lambowitz and Zimmerly, 2010). 
Retrohoming occurs through an excised lariat intron RNA reverse splicing into a DNA 
target site, followed by reverse transcription of the integrated intron into the genome 
(Figure 1.1) (Smith et al., 2005). Group II introns have been observed to retrohome into 
specific DNA target sites at frequencies approaching 100%. However, in a process 
termed retrotransposition group II introns insert into ectopic sites that resemble the DNA 
target site (Lambowitz and Zimmerly, 2004). 
Group II introns are found within the genomes of bacteria and eukaryotic 
organelles. Under physiological conditions, group II intron splicing is assisted by the 
intron-encoded protein (IEP). The IEP consists of a reverse transcriptase domain, a 
maturase domain used in intron splicing, a DNA binding domain, and an endonuclease 
domain used during second strand cleavage (Figure 1.5) (Lambowitz and Zimmerly, 
2010). The reverse transcriptase domain contains eight conserved sequence motifs, RT0 – 
RT7 (Zimmerly et al., 2001). The sequence motifs RT1- RT7 are also found in retroviral 
and other RTs. The upstream sequence motif, RT0, is characteristic of the RTs encoded 
by non-LTR retrotransposons (Malik et al., 1999; Zimmerly et al., 2001).  
Intron-encoded proteins are divided into nine major lineages termed 




Toro et al., 2002; Zimmerly et al., 2001) (Figure 1.2). The best-characterized group II 
intron is L1.LtrB from Lactococcus lactis, which encodes the protein LtrA. The L1.LtrB 
intron RNA belongs to structural subclass IIA1 of the mitochondrial lineage (Zimmerly et 
al., 2001). While LtrA contains an endonuclease domain, not all group II intron-encoded 
proteins contain the domain (San Filippo and Lambowitz, 2002). Half of the bacterial 
classes (including all members of C, D, and E), and some of the organelle IEPs do not 
contain an endonuclease domain, yet many of these introns retain their ability to 
retrohome (Dai and Zimmerly, 2002a; Martinez-Abarca and Toro, 2000).  
1.1 Mechanism of group II intron mobility  
Group II introns splice through two sequential transesterification reactions that 
results in an excised intron lariat with a 2’-5’ phosphodiester bond and ligated exons 
(Peebles et al., 1986; Schmelzer and Schweyen, 1986) (Figure 1.3).  The splicing reaction 
is catalyzed by the intron RNA, which folds into a conserved secondary structure 
consisting of six double-helical domains (DI-DVI) arranged around one central circle 
(Michel and Ferat, 1995; Qin and Pyle, 1998) (Figure 1.4). DV interacts with DI to form 
the active site in the catalytic core. DIV contains the open reading frame that encodes the 
group II intron protein. DI contains sequences EBS1 and EBS2 (exon-binding sites 1 and 
2) which base pair with the 5’- exon sequences, IBS1 and IBS2 (intron-binding sites 1 
and 2). The sequence adjacent to EBS1, δ, base pairs with the first nucleotides of the 3’- 
exon, δ’ (Lambowitz and Zimmerly, 2004). These base pairing interactions help position 




Group II intron mobility occurs through several steps involving the intron RNA 
and IEP (Matsuura et al., 2001; Saldanha et al., 1999). First, the IEP assists intron 
splicing by stabilizing the catalytically active RNA structure (Figure 1.1).  The IEP then 
remains associated with the excised intron lariat RNA forming a ribonucleoprotein 
particle (RNP) (Matsuura et al., 2001; Saldanha et al., 1999). The RNP next recognizes 
the DNA target site by the IEP interacting with the 5’- and 3’- exons target sequences, 
and EBS-IBS base-pairing interactions with the intron RNA (Mohr et al., 2000; Singh 
and Lambowitz, 2001).  Following recognition of the DNA target site, the intron RNA 
reverse splices directly into the DNA strand and bottom-strand cleavage is catalyzed by 
the endonuclease domain (Guo et al., 1997; Mohr et al., 2000). Second strand cleavage 
creates a primer, which is used to reverse transcribe the intron into single-stranded 
complementary DNA (cDNA) (Matsuura et al., 1997; Mohr et al., 2000). Lastly, the 
cDNA is integrated into the genome through cellular DNA recombination or repair 
mechanisms (Smith et al., 2005).  
1.2 Endonuclease-independent retrohoming  
The endonuclease domain contains amino acid residue sequence motifs 
characteristic of the H-N-H family of DNA endonucleases, with one catalytically 
essential Mg2+ ion at the H-N-H active site (San Filippo and Lambowitz, 2002). 
Additionally, the endonuclease domain contains two pairs of conserved cysteine pairs 
(denoted CX2C/1 and CX2C/2) that help maintain the domain’s higher-order structure 
(Gorbalenya, 1994; San Filippo and Lambowitz, 2002; Shub et al., 1994).  Endonuclease 




(Matsuura et al., 1997; Zimmerly et al., 1995). However, deletion of the conserved 
endonuclease domain of LtrA inhibits reverse transcription, possibly because it interacts 
with and stabilizes the reverse transcriptase domain (San Filippo and Lambowitz, 2002). 
For all characterized group II introns, interaction between the IEP and specific residues in 
the 3’-exon is required for endonuclease cleavage (Singh and Lambowitz, 2001). The 
cleavage site for group II introns varies, with LtrA cleaving between 3’ exon positions +9 
and +10 (Matsuura et al., 1997).  
Several IEPs lack the DNA endonuclease domain (Dai and Zimmerly, 2002a; 
Martinez-Abarca and Toro, 2000). The best characterized is the catalytically active group 
II intron from Sinorhizobium meliloti, RmInt1, which despite lacking the endonuclease 
domain retrohomes efficiently using endonuclease-independent retrohoming (Munoz-
Adelantado et al., 2003). Endonuclease-independent retrohoming occurs by the group II 
intron reverse splicing into double-stranded or transiently single-stranded DNA followed 
by reverse transcription of the intron using a nascent DNA strand at the replication fork 
as a primer (Figure 1.6). The primer can be either a leading (LEAD) or lagging (LAG) 
DNA strand (Zhong and Lambowitz, 2003). LtrA predominantly retrohomes using 
endonuclease-dependent bottom-strand cleavage (Dickson et al., 2001). However, LtrA 
retrohomes at lower frequencies using endonuclease-independent mobility with a 
leading-strand orientation bias (Dickson et al., 2001; Zhong and Lambowitz, 2003).  
1.3 Group II introns from Thermosynechoccus elongatus 
 The thermophilic bacteria Thermosynechoccus elongatus (T. elongatus) was 




elongatus is a cyanobacterium with an optimal growth temperature of 55°C . The closest 
known relative of the T. elongatus introns is the previously characterized Escherichia coli 
intron EcI5, with about 50% sequence identity (Mohr et al., 2010; Zhuang et al., 2009). 
The EcI5 and T. elongatus introns belong to the chloroplast-like IIB1 subclass (Dai and 
Zimmerly, 2002b; Mohr et al., 2010). Seventeen of the T. elongatus introns do not 
encode proteins (TeI3a– t), while eight of the introns contain open reading frames (ORF) 
that encode IEPs (TeI4a- h) (Mohr et al., 2010). Five of the ORFs are interrupted by the 
insertion of an ORF-less intron, also known as a twintron (Dai and Zimmerly, 2002a; 
Mohr et al., 2010). 
Most bacterial genomes contain only one or two group II introns (Dai and 
Zimmerly, 2002a). The group II introns from T. elongatus proliferated to high numbers 
using several mechanisms (Mohr et al., 2010). First, the introns’ EBS sequence diverged 
into six different families allowing the introns to target different sites. Second, the IEPs 
likely evolved to have less intron specificity, enabling the IEP to mobilize ORF-less 
introns. Lastly, higher temperatures promoted DNA strand separation, allowing the target 
site to be recognized almost entirely by intron base pairing (Mohr et al., 2010).  
1.4 Reverse transcriptase activity of TeI4c 
Group II introns from T. elongatus encode heat-stable proteins, whose reverse 
trancriptase activity could possibly be utilized commercially for applications involving 
cDNA synthesis (Vellore et al., 2004).  cDNA synthesis can be hindered by RNA 
secondary and tertiary structures, such as helices and kinks that form in the RNA; 




it was shown that TeI4c is thermally stable and active at high temperatures when fused to  
maltose-binding protein (MBP) (S. Mohr, unpublished data). However, it remained 
uncertain whether other purification tags could be utilized for biochemical applications. 
This work examines the effect that N utilization substance A (NusA) (Nallamsetty and 
Waugh, 2006), a solubility-enhancing protein, has on TeI4c reverse transcriptase activity. 
Of the eight IEPs, TeI4c has the highest reverse transcriptase activity (S. Mohr, 
unpublished data). TeI4c was found to be stable and active when N-terminally fused to 
MBP through a short five-alanine amino acid linkage or rigid fusion (Smyth et al., 2003). 
MBP is a large affinity tag that increases the solubility and stability of proteins (Kapust 
and Waugh, 1999; Nallamsetty and Waugh, 2006). The effect of the endonuclease and 
DNA binding domains on the reverse transcriptase activity of TeI4c was unknown and is 
the subject of this study.  
1.5 DNA target site recognition for TeI4c 
TeI4c recognizes 1-2 nucleotides at the 5’-exon of the DNA target site (Mohr et 
al., 2010). This interaction is required for reverse splicing into double stranded DNA; 
however, the IEP does not recognize any nucleotide in the 3’- exon (Mohr et al., 2010). 
For other characterized group II introns, the IEP is required to recognize 3’-exon 
nucleotides for endonuclease cleavage (Mohr et al., 2000). The lack of recognition of 3’ 
exon nucleotides for retrohoming by TeI4c could be explained in several ways: (1) the 5’- 
EBS/IBS interactions may be sufficient for site-specific bottom-strand cleavage, (2) 
endonuclease cleavage may not be site-specific, or (3) the introns may not rely on 




This work examines these possibilities by studying the mobility of TeI4c with and 
without the endonuclease domain (ΔEn) to determine whether TeI4c utilizes 
endonuclease-independent mobility predominantly. Additionally, the endonuclease 
activity was examined in an in vitro biochemical assay to investigate whether TeI4c has 
site-specific or non-site-specific endonuclease activity.  
1.6 Protein structure of HIV-RT and group II intron-encoded proteins  
To date, the structure of a group II intron-encoded protein has not been 
determined. However, the reverse transcriptase domain of group II intron-encoded 
proteins is homologous to that of retroviral reverse transcriptases, such as HIV-RT, 
whose structure has been determined (Kohlstaedt et al., 1992; Michel and Lang, 1985; 
Zimmerly et al., 2001). HIV-RT is a heterodimer consisting of the subunits, p66 and p51 
(Figure 1.7). Each subunit can be described as having fingers, palm, thumb, and 
connector domains. The fingers and thumb of the reverse transcriptase form a cleft with 
the palm and RT active site at the base (Kohlstaedt et al., 1992; Sarafianos et al., 2009). 
Utilizing the previously determined structure of HIV-RT (Kohlstaedt et al., 1992), a 
three-dimensional model of LtrA was proposed by threading the aligned sequence of 
LtrA’s RT, X, and DNA binding domains onto the structure of HIV-1 RT (Blocker et al., 
2005). It is predicted that group II intron IEPs form an active site similar to HIV-RT 
(Blocker et al., 2005). 
One aim of this work was to crystallize TeI4c ΔEn. Two strategies utilized to 
increase the chances of crystal formation are crystallization using a carrier protein and 




as maltose binding protein, can increase expression levels, improve protein solubility, aid 
in protein folding, and encourage the formation of a crystal lattice (Kapust and Waugh, 
1999; Smyth et al., 2003). SER addresses the problem that crystallization can be inhibited 
by the entropic behavior of large hydrophilic side chains on the protein surface. The SER 
technique changes patches of surface-exposed large, charged residues to small nonpolar 
amino acids. This reduces surface entropy and may enable crystal contacts (Avbelj and 
Fele, 1998). Surface entropy mutations of maltose binding protein have been designed 
previously and were used in this study (Moon et al., 2010) (Table 1.1). The two 
strategies, carrier proteins and surface entropy reduction, have been explored in this study 
as a means to induce crystallization of TeI4c. 
1.7 Overview of thesis research  
This thesis work examines the group II intron-encoded proteins from 
Thermosynechoccus elongatus. I addressed the following topics: 1) biotechnology 
applications of group II intron-encoded reverse transcriptases, 2) characterization of the 
intron-encoded proteins’ DNA endonuclease domain and endonuclease-independent 
retrohoming, and 3) the crystallization of group II intron-encoded proteins. The results of 









Figure 1.1: Retrohoming pathway for the L1.LtrB intron 
 
Group II intron retrohoming occurs through the following steps: (1) Transcription of the 
intron from the donor DNA, and protein-assisted splicing to form ribonucleoprotein 
particles (RNPs). (2) Cleavage of the top strand through reverse splicing of intron into the 
target DNA, followed by bottom-strand cleavage by the endonuclease (En) domain. (3) 
cDNA synthesis of the intron using the nicked second-strand as a primer. (4-7) DNA 
processing, RNA degradation, second-strand DNA synthesis, and DNA repair. Adapted 





mechanism (Luan et al. 1993; Moran and Gilbert 2002).
The protein encoded by the non-LTR-retrotransposons
cleaves a DNA target site and then uses the cleaved 3!
end as primer to synthesize a full-length cDNA of the
element’s RNA (Eickbush 2002). Here too, the mecha-
nism of late steps in retrotransposition, including sec-
ond-strand synthesis and the sealing of gaps, has re-
mained obscure.
To investigate the nature of the late steps in retrohom-
ing, we probed the role of host accessory functions. The
retrohoming pathway has been studied in both L. lactis
and E. coli and has been found to be mechanistically
similar (Cousineau et al. 1998). Reliance on the IEP, as
well as the distinctive independence of homology be-
tween donor and recipient, and the absence of coconver-
sion tracks, are all identical. Furthermore, in both sys-
tems retrohoming is independent of RecA function. For
these reasons, and because of the general availability
of DNA and RNA processing mutants in E. coli, we
selected this host in which to examine the potential
involvement of cellular factors in retrohoming. We
thereby demonstrate how a retrotransposon parasitizes
its host through exploitation of cellular nucleolytic, po-
lymerization, and repair activities, to promote its own
spread.
Results
Assays for group II intron homing in E. coli
The plasmid-based assay described by Cousineau et al.
(1998) was used to test the role of host accessory func-
tions in retrohoming (Fig. 2A). In this assay, the group II
intron donor plasmid contains drug-resistance marker
PM1, and the intron contains an additional drug-resis-
tance marker (IM), along with the group I td intron (I) in
domain IV. The loss of the td intron by self-splicing re-
ports the minimum number of homing events that have
passed through an RNA intermediate. The compatible
recipient plasmid contains the Ll.LtrB homing site (E1–
E2) and a different drug-resistance marker (PM2). After
induction of Ll.LtrB expression, plasmids are extracted
and digested with restriction enzymes to destroy the do-
nor plasmid, then retransformed into E. coli. Then, hom-
ing products are selected for the IM and recipient PM2
markers, and screened for sensitivity to the donor PM1.
Homing frequencies in the 0.1%–0.6% range (Fig. 2B,
crosses 1 and 2) could be increased to !14% with ex-
pression of the ltrA gene downstream of exon 2 to gen-
erate a smaller intron (Fig. 2B, cross 3). The enhanced
mobility frequency is thought to be due to decreased
susceptibility of the smaller intron RNA to degradation
by host nucleases (Guo et al. 2000).
A second assay, developed by Guo et al. (2000), was also
used to check mutants with the most dramatic pheno-
types (see Supplementary Tables S1–S3). In most cases,
there was good agreement on host effects between the
two assays, and where not, the disparities can be readily
explained by the differences in assay conditions. A com-
parison between the two assays and related explanations
are given in the Supplemental Material, where the assay
described in the text is referred to as assay A, and the
second assay as assay B.
To ensure that neither replication of the donor or
recipient plasmids nor intron expression was com-
promised in each of the different hosts, we performed
a gel assay on donor and recipient plasmid levels be-
fore and after induction of Ll.LtrB, as described
(Cousineau et al. 1998). Conversion of the recipient
plasmid to homing product and/or its disappearance
due to cleavage by the RNP, with subsequent plas-
mid degradation by host nucleases, were interpreted as
satisfactory expression. Additionally, LtrA expression
was confirmed in many cases on protein gels. If either or
both the replication and expression criteria were not sat-
isfied, the result of the retrohoming assay was discarded.
Loss of the td intron was also monitored to ensure that
homing events had passed through an RNA intermedi-
ate.
Figure 1. Retrohoming pathway for the Ll.LtrB intron in
L. lactis and E. coli. The steps in the pathway are as follows:
(1) Transcription from the donor template, splicing, translation
and RNP formation. The RNP consists of the intron lariat and
IEP having RT, maturase (M), and DNA endonuclease (E) activi-
ties. (2) Cleavage of recipient DNA by reverse splicing into the
top strand and endonuclease cleavage of the bottom strand, at
the sites marked ! and ", respectively. (3) cDNA synthesis.
(4–7) Extended cDNA synthesis, RNA degradation, second-
strand DNA synthesis, and repair. The order of steps 4–7 is
unknown.
Smith et al.




Figure 1.2: Phylogeny of group II intron-encoded proteins and RNA structural classes 
 
Group II intron-encoded proteins are divided into nine classes (depicted in blue) termed 
mitochondrial-like (ML), chloroplast-like (CL) 1 and 2, bacterial A-F. Each intron-
encoded protein is associated with an intron RNA structural class: IIA1, IIB1, IIB2, IIC, 

















homologous recombination and sometimes act as matu-
rases to promote RNA splicing (Belfort et al. 2002).
Whether they function similarly in group II intron splicing
and mobility is unknown.
2.5 Group II Intron Lineages
Group II intron ribozymes and IEPs function together as
RNPs, with each IEP binding specifically to the intron
RNA that encodes it. As a result, the intron RNAs and
IEPs have coevolved over long times to form phylogenetic
lineages of mobile introns (Fontaine et al. 1997; Toor
et al. 2001). This situation again contrasts with that of
group I introns, whose IEPs generally act independently
as homing endonucleases and are frequently exchanged
among introns (Belfort et al. 2002). Phylogenetic analyses
identified eight lineages of group II intron IEPs, termed
bacterial classes A-F, ML (mitochondrial-like) and CL
(chloroplast-like), the latter because they are the major
lineages in mitochondria and chloroplasts, respectively
(Zimmerly et al. 2001; Simon et al. 2008) (Fig. 3). Each
IEP lineage is associated with a specific RNA subgroup:
MLwith IIA, bacterial class C with IIC, and the remainder
with IIB RNAs. CL IEPs are associated with IIB1 and IIB2
RNAs, while bacterial A, B, D, E, and F IEPs are associated
with less typical IIB structures (Simon et al. 2009). Notably,
bacteria contain all group II intron lineages, while mito-
chondria and chloroplasts contain bothML andCL introns
but not other lineages. This distribution may reflect that
ML and CL introns were present in bacterial endosym-
bionts that colonized eukaryotes and then exchanged
between the two organelles.
3 REACTIONS CATALYZED BY GROUP II
INTRON RNAS
Group II ribozymes catalyze their own splicing via two
sequential transesterification reactions (Fig. 4A). In the
first step, the 2! OH of the bulged A in DVI acts as the
nucleophile to attack the 5!-splice site, producing an intron
lariat/3!-exon intermediate. In the second step, the 3! OH
of the cleaved 5! exon is the nucleophile and attacks the
3!-splice site, resulting in exon ligation and excision of an
intron lariat RNA. Some group II introns self-splice in
vitro, but the reaction is generally slow (kobs! 0.2 2 1.0 "
1022 /min) and requires nonphysiological conditions—
e.g., high concentrations of monovalent salt and/or Mg++
(Jarrell et al. 1988b; Daniels et al. 1996; Hiller et al. 2000),
reflecting that proteins are needed to help fold group II
intron RNAs into the catalytically active structure for
efficient splicing. An important variation of the splicing
reaction, termed “hydrolytic splicing,” involves the use of
water as the nucleophile for the first transesterification
reaction, rather than the 2! OH of the bulged A of DVI
(Fig. 4B) (van der Veen et al. 1987; Jarrell et al. 1988b).
Some group II introns can splice exclusively via this path-
way in vivo (Podar et al. 1998a; Bonen 2008).
The active site for the splicing reaction contains at least
two specifically bound Mg++ ions, which appear to be as-
sociated with the AGC triad and AY bulge in DV based on
thio substitution/rescue and metal ion cleavage experi-
ments (Chanfreau and Jacquier 1994; Sigel et al. 2000;
Gordon and Piccirilli 2001; Gordon et al. 2007). For group
I introns, Rp- and Sp-phosphorothioate substitutions at
the splice sites have opposite effects on the two transester-
ification steps, which are simple reversals of each other at
the same active site (McSwiggen and Cech 1989). By con-
trast, group II and spliceosomal introns show strong sensi-
tivity to Rp but not Sp substitutions for both steps (Moore
Figure 3.Group II intron lineages. The major lineages of group II in-
tron IEPs, denoted CL (chloroplast-like), ML (mitochondrial-like),
and bacterial classes A-F, are shown as blue sectors. Notable
sublineages, including four subdivisions of CL and a subclass of
IIC introns that inserts after attC sites, are s ow as darker blue sec-
tors within the major lineages. RNA structural subgroups that corre-
spond to IEP lineages are shown in magenta. All group II intron
lineages and RNA types are found in bacteria. Lineages and RNA
types also found in organelles are delineated in green (outer circle).
Note that theremay be limited exceptions to the overall pattern of co-
evolution within the CL group, with different sublineages possibly
having exchanged IIB RNA structures (Simon et al. 2009). An alter-
nate nomenclature for group II lineages has been proposed, which
does not distinguish between IEP and ribozyme lineages or take
into account exceptions to their coevolution (Toro et al. 2002).
A.M. Lambowitz and S. Zimmerly
6 Advanced Online Article. Cite this article as Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a003616








Group II introns splice though two transesterification reactions. First, a 2’ OH from the 
internal adenosine of domain DVI acts as a nucleophile, attacking the 5’-splice site. This 
results in a lariat/3’-exon intermediate. Second, the 3’ OH from the cleaved 5’-exon acts 
a nucleophile, attacking the 3’-splice site. This results in exon ligation and the formation 
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Figure 1 Group II intron RNA splicing mechanism and secondary structure. A. Splic-
ing occurs via two sequential transesterification reactions. In the first, nucleophilic
attack at the 5!-splice site by the 2! OH of a bulged A-residue in DVI results in cleav-
age of the 5!-splice site coupled to formation of lariat intermediate. In the second,
nucleophilic attack at the 3!-splice site by the 3! OH of the cleaved 5! exon results in
exon ligation and release of the intron lariat. B. The conserved secondary structure
consists of six double-helical domains (DI-DVI) emanating from a central wheel, with
subdomains indicated by lower-case letters (e.g., DIVa). The ORF is encoded within
DIV (dotted loop), and DIVa is the high-affinity binding site for the IEP. Greek letters
indicate sequences involved in tertiary interactions. EBS and IBS refer to exon- and
intron-binding sites, respectively. Some key differences between subgroup IIA, IIB,
and IIC introns are indicated within dashed boxes, but additional smaller differences
are not shown (see References 69, 109 for detailed discussion of differences between




Figure 1.4: Group II intron RNA secondary structure 
 
 
The secondary structure of L1.LtrB consists of six double-helical domains (DI- DVI) 
radiating from a central wheel. Domain IV contains the open reading frame encoding 
LtrA. Domain I contains the exon-binding sites (EBS1, EBS2) which base pair with the 
5’-exon intron-binding site sequences (IBS1, IBS2). δ base pairs with the first 1-3 















Figure 1.5: Schematic of a group II intron-encoded protein 
 
Group II intron-encoded proteins are multidomain proteins consisting of the following 
domains: reverse transcriptase (RT), maturase (X), DNA binding (D), and endonuclease 
domains (En). The reverse transcriptase domain consists of the conserved sequence 
blocks RT1- RT7, which are characteristic of the finger and palm regions of retroviral 
RTs. The RT0 sequence block is characteristic of RTs encoded by non-LTR 
retrotransposons. The maturase domain (X) corresponds to the thumb in retroviral RTs. 
The DNA endonuclease domain (En) is used in bottom-strand cleavage. Adapted from 















smaller deletion in DIV has co-varied with the terminal loop of
DIVa1 in a manner suggesting a base-pairing interaction between
the loops (Figure 2C). As DIVa is a critical binding region for the
IEP in subgroup IIA introns [30], these changes could be pertinent
to IEP recognition.
The T. elongatus Introns Have Diverged into Six Families
with Different Target Sites
Group II introns recognize DNA target sequences by using both
the IEP and base pairing of the intron RNA [31,32]. In group IIB
introns, the base-pairing interactions involve intron RNA
sequences denoted EBS1, 2, and 3 and complementary DNA
target sequences denoted IBS1 and 2 in the 59 exon and IBS3 in
the 39 exon [28,33,34]. We noticed that the T. elongatus introns
could be divided into six families, F1–F6, based upon their EBS1,
2 and 3 sequences (Figure 1), and phylogenetic analysis indicated
that each of these families corresponds to a distinct clade (Figures 3
and S3). Most of the introns are inserted at genomic sites with
largely complementary IBS sequences (one or no mismatches),
suggesting insertion by retrohoming, but some are inserted at sites
with more poorly matched IBS sequences, suggesting insertion by
infrequent retrotranspositions. Because the EBS/IBS interactions
in the precursor RNA are required for RNA splicing, only those
introns inserted by retrohoming at sites with complementary IBS
sequences are expected to splice efficiently. Most introns with
poorly matched IBS sequences and some introns with well-
matched IBS sequences are inserted at sites in intergenic regions,
where their splicing ability is less likely to affect host gene
expression.
The eight ORF-containing introns are divided into two families
(F1 and F2), while the 17 ORF-less introns are divided into four
families (F3–6; Figure 1). The F1 introns (TeI4a–e) are inserted in
intergenic regions, as are two of the F2 introns (TeI4f and 4g).
Notably, the 59 exon of TeI4f and the 39 exon of TeI4g correspond
to 59 and 39 segments of an ABC transporter pseudo-gene,
respectively, suggesting these introns were derived from an exon-
shuffling homologous recombination event between two ancestral
introns. The remaining F2 intron, TeI4h, is inserted in a gene
encoding the single copy of tRNAIle
CAU, which is putatively
essential [26]. The site of insertion in the tRNA gene is one with
good EBS/IBS pairings, suggesting that TeI4h inserted by
retrohoming and can splice to produce a functional tRNA.
F3 consists of seven identical ORF-less introns, five of which
(TeI3a–e) are inserted at a conserved site between the two closely
Figure 2. T. elongatus group II intron RNA secondary structure and IEP. (A) Predicted secondary structure of TeI4h. Differences in TeI4c, TeI4f,
and TeI3c are indicated in red, boxed, and blue letters, respectively. The structure consists of six conserved domains (DI–DVI). Subdomains and further
subdivisions are denoted with letters followed by numbers (e.g., DIc1). Greek letters indicate nucleotide seque ces involved in long-range tertiary
interactions [2]; 59 and 39 exon (E1 and E2, respectively) are boxed; and splice sites are indicated by open arrowhe ds. The gray boxes show a region
of DIII that is replaced by a different sequence in TeI3c (blue, inset). (B) Secondary structur of DIV of ORF-containing TeI4 introns. The figure shows
the secondary structure of DIV of TeI4h, with differences in TeI4c, 4f, and 4g indicated in ed, b xed, and whi e letters in black boxes, respectively. T e
two potential start codons and the stop codon of the intron ORF are circled, and the arrow b tween the two potential start co ons indicates the site
at which TeI3c and other F3 introns insert into TeI4c and other F1 introns, resulting in th formation of twintrons. Regions that differ substantially in
the ORF-less TeI3 introns are shaded gray. (C) Secondary structure of DIV of the ORF-less TeI3 introns. The figure shows the secondary structure of
TeI3c, with differences in TeI3f, 3k, and 3l indicated in orange, green, and purple, respectively. Regions that differ from the ORF-containing TeI4
introns are shaded gray. Potential base pairings between the DIVa1 and DIVa2 loops are indicated at the upper right. A red circle highlights the extra
U residue in DIVa1 of ORF-less introns (see also Figure S2). (D) Schematic of the TeI4h IEP. Conserved protein domains are: RT, containing conserved
amino acid sequence blocks RT1–7 characteristic of the finger and palm regions of retroviral RTs; X/Thumb, region associated with maturase activity
and corresponding in part to the RT thumb; D, DNA binding; and En, DNA endonuclease; RT-0 is a region conserved in the RTs of non-LTR
retroelements [1,29]. Multiple sequence alignments of the TeI4h and other IEPs are shown in Figure S1.
doi:10.1371/journal.pbio.1000391.g002
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Figure 1.6: Endonuclease-independent retrohoming mechanisms 
 
Models for group II intron mobility using leading and lagging-strands at the replication 
fork to prime reverse transcription. Retrohoming is shown through reverse splicing into 
double-stranded DNA and using the (A) leading strand or (B) lagging strand at the 
replication fork as a primer. (A) The leading strand is directly used as a primer before the 
replication fork passes. (B) The lagging strand is used a primer after the replication fork 
has traversed the inserted intron RNP. (C) The group II intron reverse splices into single-
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Ribbon diagram of HIV-RT in complex with nucleic acid. HIV-RT is a heterodimer 
consisting of the subunits p66 and p51. The p66 subunit: fingers, palm, thumb, 
connection and RNase H domains are depicted in blue, red, green, yellow, and orange, 
respectively. The p51 subunit is depicted in brown. The template nucleic acid is depicted 
in gray. The fingers and thumb of the reverse transcriptase form a cleft with the palm and 















Ribbon representation of HIV-1 RT in a complex with nucleic acid. The fingers, palm, thumb,
connection, and RNase H subdomains of the p66 subunit are shown in blue, red, green, yellow,
and orange, respectively. The p51 subunit is shown in dark brown. The template and primer
DNA strands are shown in light and dark gray, respectively.
Sarafianos et al. Page 27

























Table 1.1: Surface entropy mutations for maltose binding protein  
 
TeI4c was N-terminally fused to maltose binding protein (MBP). Five vectors (A-E) were 
















method minimizes the risk of inadvertent mutagene-
sis of biologically important residues on the target
protein—a potential hazard of the SER technique.
Here, we present three case studies of unrelated tar-
get proteins (ranging in size from 198 to 324 amino
acids) whose structures were determined using this
approach.
Discussion
To date, in our laboratory, we used the tandem
fixed-arm MBP/SER mutation system toward the
crystallization of seven unrelated proteins whose
structures could not be solved by conventional
means. We have successfully solved the structures of
three of these proteins—2OST (Table I),42 RACK1A,43
and Der p 7 (Mueller et al (doi:10.1016)). We have
also obtained crystals for two (TargetA and TargetB)
of the remaining four proteins (Table III). Co-crystals
of TargetA (431 amino acids) in complex with DNA
diffract to 2.3 Å resolution. However, these crystals
are badly twinned, and simultaneously, have problems
with pseudo-symmetry. Efforts are currently under-
way to optimize the crystal growth conditions for
TargetB (292 amino acids). Thus far, the other two
proteins (Targets C and D) have not yielded diffrac-
tion-quality crystals.
Taken together, in a field where less than 10%
of expressed proteins are solved and deposited
(http://www.jcsg.org), we have increased our success
rate to over 40%, with proteins that previously have
been difficult to solve. Because of the small sample
size (n ! 7), these values may not be statistically
significant, but are definitely encouraging.
Though the MBP/SER system can increase the
likelihood of successfully crystallizing difficult pro-
teins, the approach is not infallible. There are spe-
cific issues to consider. While N-terminal fusion of
the MBP to the target protein can be beneficial for
protein expression and purification, the significant
size of the MBP may serve to limit the size of the
target protein that can then be expressed in E. coli.
Historically, MBP fusion proteins with smaller tar-
gets, relative to the size of the MBP, have yielded
more structures (Table I), though a few targets
larger than 150 residues have been determined. The
synergistic nature of the additional SER mutations
ay increase the likeliho d that a larger target pro-
tein could be crystallized. Placement of the MBP at
the N-terminus of the fusion protein is generally
considered to be advantageous due to its chaperone-
like behavior. However, in cases where the N-termi-
nus of the target protein is crucial for functionality
or for protein-protein interaction, N-terminal
MBP could be disruptive. On the other hand, it
should be noted that MBP fusion proteins have been
used to solve structures of large multi-protein
complexes.44
In short, the tandem fixed-arm MBP/SER sys-
tem represents a simple, cost-effective method for
crystallization of problematic proteins that encom-
passes the advantageous properties of carrier-driven
crystallization and surface entropy reduction. This
technique represents another tool that can be used




The pMAL-c2x (New England Biolabs) vector was
used as the backbone to create the pMALX vector,
based on the reported vector,30,36 with a few altera-
tions. The MBP amino acid sequence was originally
modified to include mutations E359A/K362A/D363A
and was truncated after Asn367, removing the Fac-
tor Xa protease cleavage site. The linker region enc-
odes three alanine residues, as in the original vec-
tor,36 but was created by insertion of NotI and NheI
restriction sites upstream of the EcoRI site in the
original pMAL-c2x multicloning region [Fig. 1(A)].








Table III. Proteins for Which the MBP(SER) System has been Thus Far Unsuccessfula
Target protein Biological role Size Crystals? Solved?
TargetA " DNA Y-family polymerase 431 amino acids Yes No (perfect hemihedral twinning)
TargetB Protein sulfotransferase 292 amino acids Yes No (insufficient diffraction quality)
TargetC " DNA X-family polymerase 357 amino acids No No
TargetD Transcriptional regulator 242 amino acids No No
a Before transferring these proteins to the MBP(SER) system, we first attempted to crystallize them alone or in the pres-
ence of ligands. Where appropriate, different species of proteins were used, utilizing multiple construct lengths in each
case. These particular target proteins displayed low solubility in the absence of a fusion partner, so SER mutations were
not used. In multiple cases, chemical modification was also used. However, these proteins generated no usable crystals.




Chapter 2:  Group II intron-encoded reverse transcriptases for biotechnology 
applications 
Reverse transcriptases (RTs) are used in biotechnology to copy RNA into DNA. 
However, the RNA template can form secondary or tertiary structures, such as kinks or 
helices, that hinder cDNA synthesis. Increasing the reaction temperature destabilizes 
secondary and tertiary structures and minimizes mispriming, thereby optimizing the 
reverse transcriptase reaction. Currently, most commercially available reverse 
transcriptases are derived from avian myeloblastosis virus (AMV) and marine leukemia 
virus (M-MLV). The commonly used thermostable RT, SuperScript III is a derivative of 
M-MLV RT and is active at temperatures up to 55°C (Potter et al. 2003).  
Group II intron-encoded proteins have inherently high processivity and fidelity, 
making them ideal candidates for a commercial reverse transcriptase.  In vivo, the IEP 
reverse transcribes the highly structured intron RNA, which is ~ 2-2.5 kb in length. 
Additionally, in vitro the TeI4c RT IEP has also been shown to be processive (S. Mohr, 
unpublished data). The L1.LtrB RT has an in vivo error frequency of 2.2 x 10-5, which is 
lower than the error frequencies of commercially available AMV RT and M-MLV RT 
(range of 4.8 x 10-5) (Bakhanashvili and Hizi, 1993; Conlan et al., 2005).  
The TeI4c protein was found to be active and thermostable when maltose binding 
protein (MBP) was N-terminally fused to TeI4c through a short rigid fusion (RF) of five 
alanines. The MBP-RF- TeI4c protein had optimal reverse transcriptase activity at 61°C 
(S. Mohr, unpublished results). This work examines the possibility that other solubility 




maltose binding protein as a commercially available RT fusion protein. NusA was N-
terminally fused to TeI4c through a rigid fusion and the reverse transcriptase activity was 
determined. This work compares the RT activity of TeI4c when fused to NusA or MBP.  
2.1 Reverse transcriptase activity of TeI4c when fused to NusA  
 A vector was constructed with TeI4c N-terminally fused to NusA through a rigid 
fusion (RF) of five alanine residues and a C-terminal His6 tag used for purification 
(Figure 2.1). The protein was expressed in E. coli and purified by a procedure that 
involves polyethylenimine (PEI) precipitation of nucleic acids followed by nickel affinity 
and heparin-Sepharose chromatography. The protein was dialyzed into buffer with 50% 
glycerol and flash frozen. Through polyacrylamide gel electrophoresis the protein was 
determined to be > 95% pure, with a yield of ~ 0.3 mg/ L.  
 The protein was assayed for reverse transcriptase activity from 25° to 77°C using 
an artificial substrate, which consisted of a poly(rA) template annealed to a 42-nucleotide 
oligo(dT) primer. The activities of TeI4c with either the NusA or MBP tag were assayed 
by quantifying the polymerization of 32P- dTTP. NusA-RF-TeI4c was active at high 
temperatures with an optimum temperature range of 41° to 65° C (Figure 2.2). The 
reverse transcriptase activity significantly decreased at 73°C. Compared to MBP-RF-
TeI4c, NusA-RF-TeI4c was ~ 3 fold less active, though both constructs have a similar 
optimal RT temperature range from 41°C to 65°C.  
2.2 Discussion  
 When expressed as either a NusA or MBP N-terminal fusion the TeI4c protein 




than the protein fused to MBP. Thus, different solubility tags can vary in their 
effectiveness at stabilizing the reverse transcriptase of group II introns IEPs. At present, 
the maltose binding protein tag provides the best, known solubility tag for TeI4c 
biotechnology applications. 
2.3 Materials and Methods 
Recombinant plasmids 
 The TeI4c RT protein was fused to an N-terminal NusA tag and MalE tag via a 
rigid five-alanine linker. The pMalE-RF-TeI4c was constructed previously (S. Mohr, 
unpublished data). pNusA-RF-TeI4c-His6 was constructed by PCR amplification of 
pMalE-RF-TeI4c with primers that append the restriction enzymes SacII and KpnI.  The 
PCR product was then cloned into the corresponding sites of pET-50b(+) (Novagen), a 
vector for expressing proteins with NusA fusions. Through PCR mutagenesis the last two 
charged residues (D and E) of NusA were replaced with alanines, and the existing linker 
(NICWFGDEATSGSGH6) was replaced by the rigid fusion linker (NICWFGAAAAA). 
Two N-terminal His6 tags were removed, and a C-terminal His6 tag was added to 
facilitate purification. 
Expression and purification 
 pNusA-RF-TeI4c was expressed in E. coli ScarabXpress T7lac competent cells 
(Scarab Genomics). Cells were grown in Terrific Broth (TB) until an optical density of ~ 
1.4 – 1.6 (OD600), were induced with 0.5 mM IPTG, and grown for an additional 48 h at 
18° C. Cells were pelleted and resuspended in nickel buffer A (20 mM Tris-HCl pH 7.5, 




three cycles of freeze/ thaw with 1 mg/ml lysozyme, and sonicated (Branson 450 Sonifer, 
Branson Ultrasonics, Danbury CT; two 45 sec bursts at amplitude of 60%). Nucleic acids 
were precipitated from the lysate by adding a final concentration of 0.2% 
polyethyleneimine followed by centrifugation at 12,000 x g for 15 min. The supernatant 
was then purified using a 5-ml nickel-Sepharose (GE Healthcare) column that had been 
equilibrated with nickel buffer A. The protein was eluted with nickel buffer A containing 
500 mM imidazole. The protein sample was then applied to two connected 1-ml heparin-
Sepharose (GE Healthcare) columns that had been equilibrated in heparin-Sepharose 
buffer (20 mM Tris-HCl, pH 7.5, 100 mM KCl, 1 mM DTT, 1 mM EDTA, and 20% 
glycerol) and eluted with a 20-column volume gradient of 0.1 to 1.5 M KCl. The protein 
eluted around 800 mM KCl, and the protein was pooled and dialyzed overnight into 
storage buffer (20 mM Tris-HCl pH 7.5, 0.5 M KCl, 1 mM EDTA, 1 mM DTT, 50% 
glycerol). 
Reverse transcriptase assay 
 The reverese transcriptase activity of the NusA-RF-TeI4c and MBP-RF-TeI4c 
proteins were measured from 25° to 77°C using an artificial substrate, consisting of a 
poly(rA) template annealed to a 42-nucleotide oligo(dT) primer. The reverse transcriptase 
activity was assayed by quantifying the polymerization of 32P-dTTP. The RT (NusA-RF-
TeI4c, 100 nM, MBP-RF-TeI4c, 50 nM) in RT buffer (75 mM KCl, 10 mM MgCl2, 20 
mM Tris-HCl pH 7.5, 1 mM DTT) was pre-incubated with 100 nM of the 
poly(rA)/oligo(dT)42 substrate at the reaction temperature. The reaction was then initiated 




reactions were incubated for times within the linear range (NusA-RF-TeI4c 2 min, MBP-
RF-TeI4c 1.5 min) and stopped by adding a final concentration of 250 mM EDTA. The 
reaction products were then spotted onto Whatman DE81 chromatography paper (GE 
Healthcare), washed 3 times in 0.3 M NaCl and 0.03 M sodium citrate, and scanned with 
a PhosphorImager (Typhoon Trio Variable Mode Imager; GE Healthcare). Bound 


























TeI4c was N-terminally fused to (A) maltose binding protein or (B) N utilization 
substance A through a five alanine rigid fusion (RF). (B) The C-terminus of NusA-RF-


















Figure 2.2: Reverse transcriptase activity of NusA-RF-TeI4c and MBP-RF-TeI4c 
 
Reverse transcriptase assay of the NusA-RF-TeI4c and MBP-RF-TeI4c proteins from 25° 
to 77°C using poly(rA)/oligo(dT)42 as a substrate. The activity plotted was corrected for 
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Chapter 3: Characterization of the DNA binding and DNA endonuclease domains of 
TeI4c RT 
 Deletion of the endonuclease domain of the L1.LtrB group II intron RT, the LtrA  
protein, abolishes not only bottom-strand cleavage but also reverse transcriptase activity, 
even using simple artificial template-primer substrates (San Filippo and Lambowitz, 
2002). However, not all IEPs require the endonuclease domain for reverse transcriptase 
activity. EcI5, the closest known relative to T. elongatus, is one such example (Zhuang et 
al., 2009). This work examines the effect of deleting the C-terminal DNA binding and 
endonuclease domains  on the reverse transcriptase activity for the group II intron-
encoded protein TeI4c. 
 To examine the effect of deleting the DNA binding and endonuclease domains of 
TeI4c, three C-terminal truncations were constructed denoted to identify the first 
truncated amino acid residues: Δ439, Δ484, and Δ502. The truncations were made in the 
pMalE-RF-TeI4c vector background, which encodes a N-terminal maltose binding 
protein fused through a short rigid fusion (RF) to the TeI4c RT. The reverse transcriptase 
activity of the truncations was determined through two RT assays, a poly(rA)/oligo(dT) 
assay and a primer extension assay.  
3.1 Sequence alignment of TeI4c with LtrA  
 The secondary structure and domains of LtrA have been previously predicted 
(Blocker et al., 2005; San Filippo and Lambowitz, 2002). Using this information, the 
secondary structure and domain boundaries of the TeI4c RT were predicted by aligning 




the multiple alignment program ClustalW2 (Chenna et al., 2003). The group II intron-
encoded proteins contain eight conserved reverse transcriptase sequence motifs, RT0 – 
RT7 (Zimmerly et al., 2001). The sequence motifs RT1 – RT7 are conserved in retroviral 
RTs, while the RT0 sequence is characteristic of non-LTR-retrotransposon RTs (Malik et 
al., 1999; Zimmerly et al., 2001). The alignment of LtrA and TeI4c shows conserved 
amino acids within the RT0 –RT1 sequence elements. In LtrA, seven α-helices are 
predicted downstream of the reverse transcriptase domain. Figure 3.1 includes these 
predicted α-helices in the alignment.  
 Through examination of the sequence alignment, three C-terminal truncations 
were designed: Δ439, Δ484, and Δ502. All three truncations were constructed with 
TeI4c N-terminally fused to maltose binding protein through a rigid fusion (Figure 3.2). 
All the truncations removed the C-terminal endonuclease domain. The TeI4c Δ502 RT 
removed only the endonuclease domain. The TeI4c Δ484 RT removed the α-helix, αD, 
from the DNA binding domain, and the TeI4c Δ439 RT removed the entire DNA binding 
domain.  
3.2 Reverse transcriptase activity of C-terminal truncations  
 The C-terminal truncations were constructed through PCR QuikChange site-
directed mutagenesis of the pMALE-RF-TeI4c expression plasmid using oligonucleotides 
that contained the desired deletion (Wang and Malcolm, 1999). The full-length and 





 The full-length and truncated TeI4c proteins were assayed for reverse 
transcriptase activity in vitro at 60°C using an artificial poly(rA)/oligo(dT)42 substrate. 
The C-terminal truncations, Δ502 and Δ484, displayed reverse transcriptase activity 
(Figure 3.3). The TeI4c Δ439 RT, which removed the entire DNA binding and 
endonuclease domains, displayed little or no reverse transcriptase activity. Whereas, the 
TeI4c Δ484 RT displayed  ~30% of full-length activity, the TeI4c Δ502 RT was 
surprisingly ~ 3 times more active than full-length TeI4c protein at 60° C. 
 Encouraged by these results, I then assayed the reverse transcriptase activity of 
TeI4c Δ502 at temperatures ranging from 25° to 77°C (Figure 3.4). The TeI4c Δ502 RT 
had a temperature profile similar to the full-length TeI4c protein with the TeI4c Δ502 
protein displaying ~ 2 – 3 fold more activity than the full-length protein. The TeI4c Δ502 
RT had the greatest activity at temperatures from 61° to 65°C, with its peak activity at 
61°C. 
 The processivity of the truncations were examined in vitro using a 531-nt 
transcript. The transcript was synthesized from an AflIII-digested plasmid, pBS KS(+), 
that was transcribed and then annealed to a 32P-labeled 37-nt primer (AflIII). The labeled 
transcript and truncated proteins were incubated at 60 °C for 5 min and the products were 
analyzed by electrophoresis in a denaturing 6% polyacrylamide gel (Figure 3.5). The 
TeI4c Δ502 and Δ484 RTs were processive enzymes, synthesizing full-length cDNAs. 
Similar to the poly(rA)/oligo(dT) assay, the TeI4c Δ439 protein had little to no reverse 
transcriptase activity. The TeI4c Δ484 RT had ~ 23% of the full-length protein activity, 




3.3 Discussion  
The endonuclease domain of TeI4c is not required for reverse transcriptase 
activity. Surprisingly, the TeI4c protein has significantly more RT activity in vitro 
without the endonuclease domain (Δ502). Unlike LtrA, TeI4c does not require the 
endonuclease domain to interact with the RT domain for activity (San Filippo and 
Lambowitz, 2002). Deletion of the entire DNA binding domain abolishes reverse 
transcriptase activity, and partial deletion of the DNA binding domain significantly 
decreases RT activity. The DNA binding and endonuclease domains had no affect on the 
RT’s processivity.  
3.4 Materials and Methods 
Recombinant plasmids 
 The expression plasmids pMalE-RF-TeI4c Δ502, pMalE-RF-TeI4c Δ484, and 
pMalE-TeI4c Δ439 were constructed through truncation of the pMalE-RF-TeI4c vector. 
The vector was truncated through a variation of QuikChange site-directed mutagenesis 
with large oligonucleotides that flanked the desired deletion, but did not include the 
truncation (Wang and Malcolm, 1999).  
Expression and purification  
The plasmids pMalE-RF-TeI4c Δ502, pMalE-RF-TeI4c Δ484, and pMalE-TeI4c 
Δ439 were expressed in E. coli Rossetta 2 competent cells (Novagen, EMD Biosciences, 
Gibbstown NJ). The cells were grown in Terrific Broth (TB) at 37°C until mid-log phase 
(OD600 ~1.4- 1.6), induced with 500 μM IPTG, and grown for an additional 48h at 18°C. 




7.5, 500 mM KCl, 1 mM DTT, 1 mM EDTA, 20% glycerol). The cells were disrupted 
through three freeze/thaw cycles with lysozyme (1 mg/ml of lysate), and sonicated 
(Branson 450 Sonifer, Branson Ultrasonics, Danbury CT; two 45 sec bursts at amplitude 
of 60%). The cells were centrifuged at 14,000 x g for 40 minutes. Nucleic acids were 
precipitated from the lysate by adding a final concentration of 0.2% polyethyleneimine, 
followed by centrifugation at 12,000 x g for 15 min. The supernatant was then purified 
using a 10-ml amylose column (Amylose High Flow, New England Biolabs) that had 
been equilibrated in amylose A buffer. The protein was washed with buffer containing 
1.5 M KCl, and then eluted with amylose buffer containing 10 mM maltose. The protein 
peak was pooled and applied to a heparin- Sepharose column (GE Healthcare) that had 
been equilibrated in heparin-Sepharose buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 1 
mM DTT, 1 mM EDTA, and 20% glycerol) and the protein was eluted with a 20-column 
volume gradient of 0.1 to 1.5 M KCl. The proteins eluted around 800 mM KCl, and were 
pooled and dialyzed overnight into storage buffer (20 mM Tris-HCl pH 7.5, 0.5 M KCl, 1 
mM EDTA, 1 mM DTT, 50% glycerol).  
Reverse transcriptase assay 
 The activity of the MBP-RF-TeI4c, MBP-RF-TeI4c Δ502, MBP-RF-TeI4c Δ484, 
and MBP-RF-TeI4c Δ439 proteins (100 nM) was measured at 60°C with the 
poly(rA)/oligo(dT)42 substrate (100 nM). Additionally, the activity of the MBP-RF-TeI4c 
and MBP-RF-TeI4c Δ502 proteins (50 nM) was measured from 25°- 77°C.  The RTs 
were pre-incubated with the poly(rA)/oligo(dT)42 substrate at the reaction temperature, 




Elmer, Waltham MA). The reactions were incubated for 1.5 min, and terminated by 
adding EDTA to a final concentration of 250 mM. The products were spotted onto 
Whatman DE81 chromatography paper (GE Healthcare), washed three times in 0.3 M 
NaCl and 0.03 M sodium citrate, and scanned with a PhosphorImager  (Typhoon Trio 
Variable Mode Imager; GE Healthcare).  
 Reverse transcriptase activity was also determined through a primer extension 
reaction using a pBSAflIII 531-nt RNA template that was annealed to the oligonucleotide 
AflIII (AflIII primer: 5'- CCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCG). 
The RNA template was made by digesting the plasmid pBluescript (+) KS with AflIII 
and then transcribed using T7 Megashortscript (Ambion, Austin, TX). The 
oligonucleotide AflIII was designed to be complementary to the 3’- end of the RNA 
template. The primer was 32P-labeled with T4 polynucleotide kinase (New England 
Biolabs) and annealed to the RNA template at 82°C for 2 min. The RT (100 nM) and 
RNA substrate (30 nM) in primer extension buffer (750 mM KCl, 100 mM MgCl2, 200 
mM Tris-HCl pH 7.5, 1 mM DTT) were pre-incubated for one min at 60°C. The reaction 
was initiated by adding pre-warmed to reaction temperature, dNTPs to a final 
concentration of 2 mM. The reaction was incubated for 5 min, and terminated by adding 
a final concentration of 250 mM EDTA and 0.1% SDS. The product was phenol-







Figure 3.1: Sequence alignment of LtrA and TeI4c 
 
Sequence alignment of LtrA and TeI4c using ClustalW2 (Chenna et al., 2003). The 
conserved reverse transcriptase domains, RT0 –RT7, are indicated in blue boxes. Alpha 
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TeI4c was N-terminally fused to maltose binding protein (MBP) through a rigid linker of 
five alanines. Three C-terminal truncations were constructed (a) Δ439, (b) Δ484, and (c) 
































The reverse transcriptase activity of full-length and truncated TeI4c protein (Δ502, Δ484, 
and Δ439; 100 nM) were assayed using an artificial poly( rA)/oligo(dT) substrate at 60°C 




















The reverse transcriptase activity of the MBP-RF-TeI4c and MBP-RF-TeI4c Δ502 
proteins (50 nM) were measured using a poly(rA)/oligo(dT)42 substrate (100 nM) from 








































































The top and bottom panels show the full-length product and unextended primer, 
respectively. The bar graphs below show the percentage of primer extended to full-length 
cDNA. (A) Reaction shown in duplicate: TeI4c, TeI4c Δ484, and TeI4c Δ439. (B) 













Chapter 4: Biochemical characterization of the endonuclease domain of TeI4c and 
its utilization in retrohoming 
LtrA and other characterized group II intron-encoded proteins require that the IEP 
recognize the 5’-exon and 3’-exon for reverse splicing and bottom-strand cleavage, 
respectively (Guo et al., 1997; Saldanha et al., 1999). A previous study examined TeI4c’s 
ability to recognize the DNA target site. The TeI4c IEP was found to recognize specific 
nucleotide residues in the 5’-exon region of the DNA target site (Mohr et al., 2010; Mohr 
et al., 2000). However, the TeI4c IEP did not recognize a nucleotide in the 3’- exon as 
required by other characterized group II introns for bottom-strand DNA cleavage (Mohr 
et al., 2010). The lack of 3’-exon recognition suggests several possible mechanisms that 
could be used in TeI4c mobility: (1) 5’-EBS/IBS interactions may be sufficient for 
endonuclease cleavage, (2) bottom-strand cleavage is not site-specific, or (3) the intron 
may not rely on endonuclease cleavage and use endonuclease-independent mobility for 
retrohoming (Mohr et al., 2010). This chapter examines the ability of the TeI4c IEP to 
use endonuclease-independent mobility through a plasmid-based mobility assay, which 
compares the retrohoming efficiency of full-length TeI4c protein to TeI4c Δ502 protein. 
Additionally, this chapter examines the biochemical activity of the TeI4c protein through 
an in vitro endonuclease assay using reconstituted ribonucleoproteins (RNPs) to cleave 
32P end-labeled DNA target-site substrates.  
The closest known relative of T. elongatus is EcI5 (Mohr et al., 2010). Although 
EcI5 contains an endonuclease domain, it can also use En-independent retrohoming 




TeI4c does not require the endonuclease domain for reverse transcriptase activity. These 
findings suggest TeI4c may be similar to EcI5 and not require the endonuclease domain 
for retrohoming. It is feasible that TeI4c utilizes En-independent retrohoming, entirely or 
partially, for mobility. 
The endonuclease activity of several group II intron-encoded proteins has been 
previously characterized (Lambowitz and Zimmerly, 2010). The top strand is cleaved as 
the intron reverse splices into the target site. All characterized group II introns cleave the 
top strand at the intron insertion site (Lambowitz and Zimmerly, 2010; Matsuura et al., 
1997; Zhuang et al., 2009). However, cleavage of the bottom strand by the endonuclease 
domain varies with the group II intron. LtrA cleavage occurs at position +9 of the 3’ exon 
(Matsuura et al., 1997). The endonuclease cleavage for the yeast mitochondrial DNA 
group II introns, aI1 and aI2, occurs at position +10 of the 3’ exon (Lambowitz and 
Zimmerly, 2010). This work characterizes the endonuclease activity of the TeI4c protein.  
4.1 Endonuclease-independent retrohoming of TeI4c 
Mobility assays were performed using an in vivo plasmid-based mobility assay 
(Guo et al., 2000; Karberg et al., 2001). The mobility assay uses two vector constructs to 
measure retrohoming events: a donor vector containing an ORF-less intron RNA 
upstream of the intron-encoded protein, and a recipient vector containing the DNA target 
site (Figure 4.1). The chloramphenicol-resistant donor plasmid uses a T7Lac promoter to 
express the ORF-less intron and the IEP. The intron RNA carries a T7 promoter sequence 
in DIV. The recipient plasmid contains the target sites (ligated E1-E2 sequences) 




E. coli HMS174(DE3) cells, which contain an IPTG-inducible T7 RNA polymerase that 
induces intron expression with IPTG. As the intron carrying the T7 promoter integrates 
into the target site, the tetracycline-gene is activated, allowing for the selection of 
retrohoming events (Guo et al., 2000; Mohr et al., 2010).  
This work examines the possibility that TeI4c retrohomes through endonuclease-
independent pathways. En-independent pathways use nascent strands at DNA replication 
forks as primers for reverse transcription. The primer can be from either a leading 
(LEAD) or lagging (LAG) DNA strand. The intron encoded protein, LtrA has previously 
shown to have a bias for using the nascent leading strand primer during retrohoming 
(Zhong and Lambowitz, 2003). The orientation bias for TeI4c was examined by cloning 
its DNA target site in opposite directions relative to the direction of plasmid replication 
(Figure 4.1). The recipient constructs were designed to contain the DNA target sequence 
in the sense (LEAD) and anti-sense (LAG) orientations.  
The TeI4c intron is interrupted by the insertion of a ORF-less intron, TeI3c (Mohr 
et al., 2010). This set of nested introns is known as a twintron (Dai and Zimmerly, 2002a; 
Mohr et al., 2010). The TeI4c IEP is able to mobilize both the TeI4c intron (~2.6 x 10-2 
mobility efficiency) and ORF-less TeI3c intron (~ 6.7% mobility efficiency) (Mohr et al., 
2010). This portion of the study examines the ability of the TeI4c Δ502 IEP to promote 
retrohoming of the TeI3c and TeI4c introns through endonuclease-independent pathways. 
The mobility of the TeI4c Δ502 IEP was compared with the full-length TeI4c IEP. Donor 
constructs were designed that encoded either a TeI3c or TeI4c intron upstream of either a 




The donor constructs were designed to encode either a TeI3c or TeI4c intron 
upstream of either the full-length or TeI4c Δ502 IEP (pACD42-3c4c Retarget, pADC42-
3c4cΔ502 Retarget, pACD2x TeI4c4c, pACD2xTeI4c4c Δ502). The TeI3c intron donor 
construct, pACD42 3c4c Retarget, and its recipient, pBRRX +42, had been used 
previously for retargeting to optimize mobility (G. Mohr, unpublished data). 
Additionally, the mobility of the TeI4c IEP increases significantly when the TeI4b intron 
target site is used (Mohr et al., 2010). The recipient constructs were designed to contain 
the target sequence in both the sense (LEAD) and anti-sense (LAG) orientations 
(pBRRX+42 Lead/Lag, pBRR3T24b Lead/Lag). The donor and recipient vectors were 
co-transformed into E. coli HMS174(DE3) cells, induced at 48°C for 1 h, and plated onto 
LB (Luria-Bertani) plates containing tetracycline plus ampicillin or ampicillin alone. The 
mobility efficiency was calculated as the ratio of (TetR + AmpR)/AmpR colonies after 
incubation at 37°C.  
 Figure 4.2 summarizes the mobility data for donor plasmids expressing full-length 
and TeI4c Δ502 protein. The full-length TeI4c IEP mobilized the TeI3c intron with a 
mobility efficiency of ~74% for both the leading and lagging strand constructs. The 
TeI4c  Δ502 IEP mobilized the TeI3c intron with a mobility efficiency of ~13%, a 5-fold 
decrease from full-length TeI4c. The TeI4c 502 IEP with TeI3c intron also displayed a 
pronounced replication orientation bias (~8 fold) for using a nascent leading DNA strand 
as a primer during reverse transcription.  
The full-length TeI4c protein with TeI4c intron had a mobility efficiency of ~30% 




had a mobility efficiency of ~1.5%, a 20-fold decrease from full-length TeI4c IEP. The 
TeI4c Δ502 IEP with TeI4c intron also displayed a replication orientation bias (~10 fold) 
for the nascent leading strand. 
Together, the results above show that the TeI4c full-length protein, with either the 
TeI3c or TeI4c introns, does not have a strand preference for priming reverse 
transcription. However, the TeI4c Δ502 IEP has a leading strand preference with both 
introns. The lack of bias for the full-length TeI4c protein for both introns indicates that 
retrohoming occurs by reverse splicing into double-strand DNA and use of the 
endonuclease domain for bottom-strand cleavage to generate the primer for reverse 
transcription. The leading-strand bias for TeI4c Δ502 IEP for both introns indicate that in 
the absence of endonuclease cleavage retrohoming occurs preferentially by reverse 
splicing into double-stranded DNA and use of a nascent leading strand as a primer for 
reverse transcription. 
4.2 Endonuclease activity of TeI4c 
 The in vitro endonuclease activity of the TeI4c IEP with the TeI3c and TeI4c 
intron was assayed by incubating ribonucleoprotein (RNP) particles with small (100 and 
88 bp respectively) end-labeled DNA substrates. The lariat RNPs were prepared through 
protein-assisted splicing (full-length and TeI4c Δ502) of the transcribed intron precursor 
at 50°C for 1 h, followed by ultracentrifugation overnight. The 32P end-labeled DNA 
substrate was made by designing long oligonucleotides, sense and anti-sense, that when 
annealed together contained the intron insertion site (ligated E1 and E2). The 




their respective complementary unlabeled oligonucleotide to make the double-stranded 
DNA substrate. The endonuclease assay was performed by incubating the lariat RNP 
particle with the DNA substrate at 50°C for one hour. The products were phenol 
extracted, ethanol precipitated, and analyzed in a 6% polyacrylamide denaturing gel.   
The DNA substrate utilized was end-labeled (5’-sense strand and 5’-antisense 
strand).  Thus, the following products should be observed in the polyacrylamide gel: the 
complete reverse-spliced DNA, substrate, 5’-top and 5’-bottom (Figure 4.3 and 4.4). The 
5’-top is the result of partial reverse-splicing of the RNP, and the 5’-bottom from bottom 
strand cleavage by the endonuclease domain. The full-length TeI4c protein, TeI3c and 
TeI4c intron RNPs, were active and reverse-spliced into the substrate DNA. However, for 
both the TeI3c and TeI4c intron endonuclease assays, a 5’-bottom product was not 
observed. This suggests that either TeI4c RNPs do not have endonuclease activity, the 
RNPs have endonuclease activity but the assay is not sensitive enough to detect less 
specific cleavage, or conditions were not optimal for the assay. The RNPs made with the 
TeI4cΔ502 IEP, and either TeI3c or TeI4c intron, were not active for reverse splicing and 
endonuclease bottom-strand cleavage in vitro.  
4.3 Discussion 
 The TeI4c Δ502 IEP is able to retrohome through endonuclease-independent 
pathways. The TeI4c Δ502 protein has a pronounced replication orientation bias 
consistent with using the leading strand at the replication fork as a primer for reverse 
transcription. This preference arises from the intron RNA reverse splicing into a double-




strand at the replication fork as a primer for reverse transcription (San Filippo and 
Lambowitz, 2002). Reverse splicing into double-stranded DNA is biased against using 
the lagging strand primer, as the replication fork would first have to travel past the 
inserted RNP before using the lagging nascent strand as a primer. The inserted RNP 
might impede passage of the replication fork. Additionally, the replication fork might 
disrupt the inserted RNP, reducing the mobility efficiency of lagging strand retrohoming 
(San Filippo and Lambowitz, 2002).  
 The full-length TeI4c protein, unlike the TeI4c Δ502 protein, did not display a 
strand preference for using the leading or lagging strand at a replication fork. Thus, it 
seems likely that the full-length TeI4c protein is able to promote reverse splicing into 
double-stranded DNA and produce a primer through bottom-strand cleavage, which 
could then be used for reverse transcription. The group II intron-encoded protein from 
L1.LtrB, LtrA exhibits a similar leading strand preference when it lacks endonuclease 
activity. These results suggest that the TeI4c full-length protein uses its endonuclease 
domain to perform bottom-strand cleavage equally on both the leading and lagging 
strands. 
 RNPs containing the TeI4c IEP with either TeI3c and TeI4c intron RNAs could  
reverse splice into double-stranded DNA in vitro. However, the TeI4c Δ502 RNPs were 
inactive and unable to reverse splice into double-stranded DNA. Whether the IEP 
contains endonuclease activity is still unknown. Mobility assays suggest that the TeI4c 
protein uses its endonuclease domain during retrohoming to produce a primer used in 




the assay was not sensitive enough to detect less specific bottom-strand cleavage, perhaps 
because it is less specific and does not occur at a single site. It is also possible that the 
assay conditions were not optimal for bottom-strand cleavage. 
4.4 Materials and Methods 
Recombinant plasmids 
 The recipient vectors pBRR3B-LtrB (LEAD) and pBRR3A-LtrB (LAG) had been 
previously designed to contain the DNA target sites cloned in opposite orientations 
relative to the direction of plasmid direction (Zhong and Lambowitz, 2003). The intron 
target site recipient vectors (pBRRx+42, pBRR3T2-4b) were constructed by swapping 
the TeI3c and TeI4b target sequences for the LtrB target sequences in recipient vectors 
pBRR3B-LtrB (LEAD) and pBRR3A-LtrB (LAG). This was done through restriction 
enzyme digestion with AatII and SphI, followed by T4 DNA ligation. 
 The donor plasmid pACD2xTeI4c-4cΔ502 was constructed by digesting the 
plasmid pACD2xTeI4c-4c with NdeI and XhoI (Mohr et al., 2010). The TeI4cΔ502 ORF 
was PCR amplified by primers that append restriction sites for NdeI and XhoI. The PCR 
products were ligated into the digested pACD2xTeI4c-4c vector. The 
pADC42TeI3c4cΔ502 retargeted vector was made by digestion of the pACD2xTeI4c-
4cΔ502 vector with NcoI and NdeI to remove TeI4cΔ502. The NcoI and NdeI fragment 
containing the TeI4c Δ502 ORF was then ligated into the NcoI and NdeI digested vector 






Intron mobility assays 
 Intron mobility assays were performed in E. coli HMS174(DE3) competent cells 
(Novagen, Madison, WI) as previously described (Mohr et al., 2010). The following 
concentrations of antibiotics were used in the assay: ampicillin, 100 μg/ml; 
chloramphenicol, 25 μg/ml; tetracycline, 25 μg/ml. Cells were co-transformed with the 
CapR donor and the AmpR recipient plasmid and were grown in 5 ml of LB media 
containing ampicillin and chloramphenicol overnight at 37°C. A fraction (100 μl) of the 
overnight culture was used to inoculate 5 ml of fresh LB media containing appropriate 
antibiotics and grown for 1 h at 37°C. The cells were then induced for 1 h at 48°C with 
1ml of LB containing a final IPTG concentration of 500 μM. The cells were then placed 
on ice, diluted with ice-cold LB media, and plated at different dilutions onto LB agar 
plates containing ampicillin and tetracycline or ampicillin alone. The plates were 
incubated overnight at 37°C, colonies were counted, and the mobility efficiency was 
calculated as the ratio of (TetR + AmpR)/(AmpR) colonies.  
Reconstitution of group II intron RNPs 
 Lariat RNPs were made through protein-assisted splicing using purified TeI4c or 
TeI4c Δ502 proteins. The intron transcript (TeI3c and TeI4c) was transcribed overnight 
at 37°C. The RNA transcript (100 nM) was denatured by heating at 82°C for 2 min, and 
then cooling to 50°C. Buffer (10 mM Tris-HCl pH 7.5, 5 mM MgCl2, 450 mM 
ammonium chloride) was added to the splicing reaction, followed by protein (200 nM). 
The protein and transcript were incubated at 50°C for 1 h, and spun in the ultracentrifuge 




endonuclease buffer (10 mM KCl, 10 mM MgCl2, 50 mM Tris-HCl pH 7.5) and stored at 
-80°C. 
Endonuclease assay 
 Complementary oligonucleotides were designed that contained the intron 
insertion site (ligated E1 and E2) of the TeI3c and TeI4c introns. Each oligonucleotide 
was end-labeled using T4 polynucleotide kinase (NEB) and annealed with its 
complementary unlabeled oligonucleotide to make a double-stranded DNA substrate. The 
lariat RNP (20 pmol) was incubated with the DNA substrate (1 pmol) in endonuclease 
buffer at 50°C for 1 h. The reaction was then phenol extracted, precipitated with ethanol, 





























(A) The donor construct is a chloramphenicol resistant (CapR) plasmid containing the 
ORF-less intron and flanking exons. A T7 RNA polymerase promoter is located in DIV 
near the 3’ end of the intron. The IEP is downstream of the intron. The recipient construct 
is an ampicillin resistant (AmpR) plasmid containing the target site (ligated E1 and E2) 
cloned upstream of a promoter-less tetracycline (TetR) gene. When the intron, carrying 
the T7 promoter, integrates into the target site the tetracycline gene is activated. Adapted 
from Mohr et al. (2010). 
(B) The recipient constructs were designed to contain the DNA target site and tetR gene 
cloned in opposite orientations relative to the direction of plasmid replication. The 
plasmids were denoted leading (LEAD) or lagging (LAG) depending on whether the 
nascent leading or lagging strands could be used as a primer during reverse transcription. 










Figure 4.2: Mobility assays on full-length and Δ502 TeI4c protein with TeI3c and TeI4c 










The mobility assays were performed with a two-plasmid mobility system, as described in 
Figure 4.1. The donor plasmids contained full-length TeI4c protein (pACD2x TeI4c4c, 
pACD42-3c4cRetarget) or truncated TeI4c Δ502 protein (pADC42-
TeI3c4cΔ502Retarget, pACD2xTeI4c4c delta502). The recipient plasmids contained the 
TeI3c intron target site (pBRR3T2-4b Lead, and pBRR3T2-4b Lag) or TeI4c target site 
(pBRRx+42 Lead, pBRRx+42 Lag). The DNA target site was cloned in opposite 
orientations, Lead or Lag, relative to the direction of plasmid replication. The donor and 
recipient vectors were co-transformed in HMS174(DE3) competent cells, and induced 
with 500 μM IPTG at 48°C for 1 hour. The cells were spread onto plates containing 
tetracycline and ampicillin or ampicillin alone. The mobility efficiency was calculated as 
the ratio of (TetR + AmpP)/(AmpR). The full-length and TeI4c Δ502 protein mobility 
assays were performed at the simultaneously. Each assay was repeated three times. The 
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The endonuclease activity was assayed by incubating full-length or TeI4c Δ502 RNP 
particles with an 88-nucleotide DNA substrate at 50°C. The products were analyzed on a  
6% polyacrylamide denaturing gel. The asterisk (*) indicates on the gel the full-length 

























The endonuclease activity was assayed by incubating full-length or TeI4c Δ502 RNP 
particles with a 100-nucleotide DNA substrate at 50°C. The products were analyzed on a 
6% polyacrylamide denaturing gel. The asterisk (*) indicates on the gel the full-length 






Chapter 5: Crystallization of a group II intron-encoded protein 
 Crystallization trials have been ongoing to determine the structure of the group II 
intron-encoded protein TeI4c. As discussed previously, the endonuclease domain is not 
required for reverse transcriptase activity, making the smaller MBP-RF-TeI4c Δ502 
protein an ideal candidate for crystallization trials. Two techniques have been used in this 
study to increase the chances of crystal formation. The first technique is the use of a 
carrier protein, such as maltose-binding protein, to increase expression of the protein, aid 
in protein solubility and folding, and encourage the formation of a crystal lattice (Kapust 
and Waugh, 1999; Kobe et al., 1999; Smyth et al., 2003). The second technique aids 
crystallization by reducing the surface entropy (SER) of the maltose-binding protein 
(Derewenda, 2004). Since protein crystallization can be inhibited by the entropic 
behavior of large hydrophilic side chains on the protein surface, these side chains can be 
mutated to small nonpolar amino acids, reducing surface entropy and increasing the 
chance for protein crystallization (Avbelj and Fele, 1998). Five vectors containing 
surface entropy mutations in the maltose binding protein have been designed to enhance 
crystallization (Moon et al., 2010) (See Table 1.1). The pMalE-RF-TeI4cΔ502 vector 
was constructed with surface entropy mutations in the maltose-binding protein (Table 
5.1). 
5.1 TeI4cΔ502 crystallization trials 
 The pMalE-RF-TeI4cΔ502 expression plasmids and modified plasmids with the 
maltose-binding protein surface entropy mutations (Table 5.1) were used to express 




competent cells in LB medium and purified through an amlyose-affinity column and 
heperin-Sepharose column. The peak protein fractions were pooled and dialyzed 
overnight into buffer containing KCl, Tris-HCl pH 7.5, and glycerol. The protein was 
concentrated using a centrifugal protein filter (Millipore) at 4°C. The protein was then 
used to set-up 96-well sitting drop crystal trays at 22°C.  
Several protein buffer conditions were tested to find the optimal conditions to set-
down crystal trays. These conditions varied from 200 – 500 mM KCl, and 0 – 20% 
glycerol. The buffer condition, 20 mM Tris-HCl pH 7.5, 250 mM KCl, and 10% glycerol, 
kept the protein soluble and concentrated. The protein concentration were varied from 1 
to 20 mg/ml and set-down in crystal trays. The optimal protein concentration to set-down 
trays was experimentally determined to be 10 mg/ml.  Crystal trays were set-down 
utilizing commercially available 96-well screen blocks containing various salts and 
precipitants for high-throughput analysis of crystallization conditions (Crystal Screen HT, 
Index HT, PEG/ION HT, Grid Screen Salt, Salt Rx HT and PEG Rx HT) (Hampton). No 
crystallization screen tested resulted in TeI4c crystals. Other approaches will need to be 
used to explored to crystallize TeI4c. 
5.2 Discussion 
 Although initial attempts to crystallize TeI4cΔ502 have been unsuccessful, other 
techniques could be utilized to form crystals. Full-length TeI4c or other TeI4c 
truncations, such as catalytically active TeI4cΔ484, could be used in crystallization trials. 
Additionally, a different carrier protein such as N utilization substance A (NusA), which 




Surface-entropy mutations in TeI4c may also increase crystal contacts, allowing crystals 
to form. Surface entropy mutations can be predicted using online programs, such as 
SERp, that predict mutation candidates likely to enhance the protein’s crystal contacts 
(Goldschmidt et al., 2007). Lastly, the addition of a DNA or RNA substrate may 
encourage crystallization.  
5.3 Materials and Methods 
Expression vectors 
 The pMal-RF-TeI4cΔ502 surface entropy reduction (SER) constructs were 
constructed through restriction enzyme digestion of the pMalE-RF-TeI4cΔ502 and 
pMBP-SER vector cassettes with BlpI and PstI (Moon et al., 2010). The BlpI/PstI 
fragment containing the TeI4cΔ502 ORF was then ligated into the BlpI and PstI MBP-
SER digested vector, and the constructs were verified through DNA sequencing. 
Protein expression and purification 
pMalE-RF-TeI4cΔ502 and the maltose binding surface entropy mutants were 
expressed and purified as previously described for the pMalE-RF-TeI4cΔ502 protein 
with the following differences: the plasmids were transformed into ArcticExpress RIL 
(Agilent Technologies) competent cells, grown in LB medium at 30°C to an optical 
density (OD600) of ~ 1.2-1.6, and expression was induced with 1 mM IPTG at 16°C for 
24h.  
Crystallization 
 TeI4c protein was dialyzed into various buffers containing 20 mM Tris pH 7.5, 




mg/ml. Sitting drops were set-down at 22°C using commercially available 96-well 
crystallography screens containing various salts and precipitants (Crystal Screen HT, 
Index HT, PEG/ION HT, Grid Screen Salt, and PEG Rx HT) (Hampton). For each sitting 
drop, the reservoir contained 65 μl of crystallography screen solution. The pedestal 



























The TeI4c Δ502 protein was expressed in vectors with and without various surface 
entropy reduction mutations (SER). The protein was expressed in E. coli ArcticExpress 
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